Charles River Laboratories International CRL
NYSE CRL
$282.06 +8.65 (+3.16%)
As of: Sep 17, 2026 · 3:59 PM EDT

Charles River Laboratories International (CRL) Change in Acquisitions & Divestments (2009 - 2026)

Charles River Laboratories International (CRL) posted Change in Acquisitions & Divestments of $8.1 million for Q2 2026, up 178.47% on a QoQ basis from $2.9 million in Q1 2026, and up 1514.48% year-over-year from $504000.0 in Q2 2025.

Analysis

Charles River Laboratories International (CRL) Change in Acquisitions & Divestments (2009 - 2026) Analysis & Trends

Charles River Laboratories International has reported Change in Acquisitions & Divestments for 18 years, with the latest figure at $8.1 million in Q2 2026.

  • On a quarterly basis, Change in Acquisitions & Divestments rose 1514.48% year-over-year to $8.1 million in Q2 2026; TTM through Jun 2026 was $18.1 million, a 42.56% decrease from a year earlier, with the FY2025 full-year figure at $9.1 million, down 78.17% from the prior year.
  • Change in Acquisitions & Divestments was $8.1 million for Q2 2026 at Charles River Laboratories International, up from $2.9 million in the prior quarter.
  • The five-year high for Change in Acquisitions & Divestments was $27.1 million in Q3 2024, with the low at $205000.0 in Q1 2022.
  • Average Change in Acquisitions & Divestments over 5 years is $4.3 million, with a median of $2.7 million recorded in 2023.
  • The sharpest annual moves came in 2024 and 2025: Change in Acquisitions & Divestments jumped 2584.26% in 2024, then slumped 89.62% in 2025.
  • Over 5 years, Change in Acquisitions & Divestments stood at $1.4 million in 2022, then surged by 87.82% to $2.7 million in 2023, then retreated by 18.31% to $2.2 million in 2024, then jumped by 56.29% to $3.5 million in 2025, then soared by 134.83% to $8.1 million in 2026.
  • The last three Change in Acquisitions & Divestments figures came in at $8.1 million (Q2 2026), $2.9 million (Q1 2026), and $3.5 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Iqvia Holdings 44.72 Bn 42.64 Bn 1.44 Bn
2 Medpace Holdings 17.37 Bn 16.87 Bn 201.64 Mn
3 Icon 13.65 Bn 12.72 Bn 479.29 Mn
4 Charles River Laboratories International 13.13 Bn 12.94 Bn 452.07 Mn
5 Fortrea Holdings 1.89 Bn 1.72 Bn 139.20 Mn
6 Evotec SE 574.75 Mn 148.87 Mn -
7 Ginkgo Bioworks Holdings 439.63 Mn 355.09 Mn 18.44 Mn
8 Champions Oncology 69.43 Mn 65.03 Mn 7.70 Mn
9 MindWalk Holdings 51.76 Mn 46.29 Mn 1.61 Mn
10 VivoSim Labs 1.37 Mn 1.37 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 27, 2026 8.14 Mn
Mar 28, 2026 2.92 Mn
Dec 27, 2025 3.47 Mn
Sep 27, 2025 3.53 Mn
Jun 28, 2025 504,000.00
Mar 29, 2025 1.60 Mn
Dec 28, 2024 2.22 Mn
Sep 28, 2024 27.11 Mn
Jun 29, 2024 4.86 Mn
Mar 30, 2024 7.50 Mn
Dec 30, 2023 2.71 Mn
Sep 30, 2023 1.01 Mn
Jul 1, 2023 990,000.00
Apr 1, 2023 1.95 Mn
Dec 31, 2022 1.45 Mn
Sep 24, 2022 2.90 Mn
Mar 26, 2022 205,000.00
Dec 25, 2021 572,000.00
Sep 25, 2021 756,000.00
Jun 26, 2021 5.20 Mn